StocksFundsScreenerSectorsWatchlists
RENE

RENE - Cartesian Growth Corporation II Stock Price, Fair Value and News

11.20USD0.00 (0.00%)Market Closed

Market Summary

RENE
USD11.200.00
Market Closed
0.00%

RENE Stock Price

View Fullscreen

RENE RSI Chart

RENE Valuation

Market Cap

63.8M

Price/Earnings (Trailing)

5.57

Price/Free Cashflow

-69.11

RENE Price/Earnings (Trailing)

RENE Profitability

Return on Equity

-61.71%

Return on Assets

6.55%

Free Cashflow Yield

-1.45%

RENE Fundamentals

RENE Earnings

Earnings (TTM)

11.4M

Earnings Growth (Yr)

476.78%

Earnings Growth (Qtr)

14.88%

Breaking Down RENE Revenue

Last 7 days

0.2%

Last 30 days

0.7%

Last 90 days

1.6%

How does RENE drawdown profile look like?

RENE Financial Health

Current Ratio

0.22

RENE Investor Care

Diluted EPS (TTM)

0.41

Which funds bought or sold RENE recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 23, 2024
Spartan Fund Management Inc.
sold off
-100
-24,231
-
-%
Apr 23, 2024
Spartan Fund Management Inc.
sold off
-100
-1,296,730
-
-%
Apr 18, 2024
Wealthspring Capital LLC
reduced
-3.17
-73,430
4,112,770
4.86%
Apr 18, 2024
Wealthspring Capital LLC
reduced
-7.57
-508
1,408
-%
Mar 27, 2024
NOMURA HOLDINGS INC
reduced
-72.73
-7,679,220
2,909,280
0.01%
Mar 27, 2024
NOMURA HOLDINGS INC
unchanged
-
-2,560
17,960
-%
Feb 26, 2024
Virtu Financial LLC
sold off
-100
-441,000
-
-%
Feb 20, 2024
Quarry LP
new
-
3,041,630
3,041,630
0.47%
Feb 16, 2024
Context Capital Management, LLC
sold off
-100
-1,086,000
-
-%
Feb 16, 2024
Context Capital Management, LLC
unchanged
-
8,989,000
9,000,000
-%

1–10 of 48

Are Funds Buying or Selling RENE?

Are funds buying RENE calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own RENE
No. of Funds

Unveiling Cartesian Growth Corporation II's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 22, 2024
shaolin capital management llc
0.0%
0
SC 13G/A
Feb 14, 2024
balyasny asset management l.p.
0.00%
0
SC 13G/A
Feb 14, 2024
first trust capital management l.p.
5.22%
1,501,481
SC 13G
Feb 14, 2024
calamos investment trust/il
5.2%
5
SC 13G
Feb 12, 2024
cantor fitzgerald securities
0.0%
0
SC 13G/A
Feb 08, 2024
wealthspring capital llc
6.1%
1,766,630
SC 13G
Jan 19, 2024
highbridge capital management llc
0%
0
SC 13G/A

Recent SEC filings of Cartesian Growth Corporation II

View All Filings
Date Filed Form Type Document
Apr 10, 2024
8-K
Current Report
Mar 20, 2024
10-K
Annual Report
Mar 07, 2024
8-K
Current Report
Feb 22, 2024
SC 13G/A
Major Ownership Report
Feb 14, 2024
SC 13G/A
Major Ownership Report
Feb 14, 2024
SC 13G
Major Ownership Report
Feb 14, 2024
SC 13G
Major Ownership Report
Feb 12, 2024
SC 13G/A
Major Ownership Report
Feb 08, 2024
SC 13G
Major Ownership Report
Feb 05, 2024
8-K
Current Report

Peers (Alternatives to Cartesian Growth Corporation II)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
MID-CAP
SMALL-CAP
73.0M
-
14.10% 8.64%
-1.5K
-
- -180.97%
66.5M
-
1.47% -
50.37
-
- 488.79%
46.7M
1.5M
0.09% 169.15%
-28.29
31.99
-42.22% 44.16%
37.9M
2.6M
-9.16% -
45.45
14.64
53.92% 749.98%
33.6M
1.4M
0.46% 6.92%
-13.05
23.58
4.96% -258.60%

Cartesian Growth Corporation II News

Latest updates
news.stocktradersdaily.com • 3 hours ago
Defense World • 19 Apr 2024 • 08:04 am
MarketBeat • 19 Apr 2024 • 07:17 am
PE Hub • 24 months ago

Cartesian Growth Corporation II Earnings Report: Key Takeaways & Analysis

Balance Sheet
(In Thousands)
Balance Sheet
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q4
Assets-29.8%174,582248,752245,856243,335240,596239,025238,234--
  Current Assets309.6%33081.003826878501,0421,199--
    Cash Equivalents88.8%51.0027.00218422544661814--
Liabilities6.3%18,87017,74816,71817,91618,88916,74821,841--
  Current Liabilities601.8%1,531218301295219237229546442
Shareholder's Equity-Infinity%-18,539----18,038--21.0021.00
  Retained Earnings-4.9%-18,540-17,667-16,336-17,230-18,038-15,675-20,521-3.73-3.73
  Additional Paid-In Capital--------24.0024.00
Shares Outstanding---5,7505,7505,4845,3945,4205,0005,750
Float---245,400---230,500--
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22021Q4
Cashflow From Operations-149.7%-476-190-134-121-111-153-577-
Cashflow From Investing--------236,900-
Cashflow From Financing-Infinity%-76,636--70.00--5.00-320*238,292-

RENE Income Statement

2023-12-31
STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Operating and formation costs$ 2,032,433$ 685,056
Loss from operations(2,032,433)(685,056)
Other income:  
Change in fair value of warrant liabilities1,664,3731,706,572
Change in fair value of convertible promissory note - related party166,2471,257,068
Transaction costs allocated to warrant liabilities (195,984)
Interest earned on cash and marketable securities held in Trust Account11,642,8532,845,907
Other income, net13,473,4735,613,563
Net income$ 11,441,040$ 4,928,507
Class A ordinary shares subject to possible redemption  
Other income:  
Basic weighted average shares outstanding (in shares)21,964,76614,871,233
Diluted weighted average shares outstanding (in shares)21,964,76614,871,233
Basic net income per share (in dollars per share)$ 0.41$ 0.24
Diluted net income per share (in dollars per share)$ 0.41$ 0.24
Non-redeemable Class A and Class B ordinary shares  
Other income:  
Basic weighted average shares outstanding (in shares)5,750,0005,484,203
Diluted weighted average shares outstanding (in shares)5,750,0005,750,000
Basic net income per share (in dollars per share)$ 0.41$ 0.24
Diluted net income per share (in dollars per share)$ 0.41$ 0.24

RENE Balance Sheet

2023-12-31
BALANCE SHEETS - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Current assets  
Cash$ 50,932$ 543,667
Prepaid expenses279,102306,733
Total Current assets330,034850,400
Cash and marketable securities held in Trust Account174,252,198239,745,907
TOTAL ASSETS174,582,232240,596,307
Current liabilities  
Accrued expenses1,230,978148,911
Promissory note300,000 
Accrued offering costs 70,000
Total Current liabilities1,530,978218,911
Warrant liabilities2,162,3233,826,696
Convertible promissory note - related party, at fair value$ 3,676,6853,342,932
Notes Payable, Noncurrent, Related Party, Type [Extensible Enumeration]us-gaap:RelatedPartyMember 
Deferred underwriting fee$ 11,500,00011,500,000
TOTAL LIABILITIES18,869,98618,888,539
COMMITMENTS AND CONTINGENCIES (Note 6)
SHAREHOLDERS' DEFICIT  
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Accumulated deficit(18,540,527)(18,038,714)
TOTAL SHAREHOLDERS' DEFICIT(18,539,952)(18,038,139)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT174,582,232240,596,307
Class A ordinary shares subject to possible redemption  
Current liabilities  
Class A ordinary shares subject to possible redemption; 15,870,561 and 23,000,000 shares at redemption value of $10.98 and $10.42 per share as of December 31, 2023 and 2022, respectively174,252,198239,745,907
Class A ordinary shares not subject to possible redemption  
SHAREHOLDERS' DEFICIT  
Ordinary shares$ 575 
Class B ordinary shares  
SHAREHOLDERS' DEFICIT  
Ordinary shares $ 575
RENE
Cartesian Growth Corporation II does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities. Cartesian Growth Corporation II was incorporated in 2021 and is based in New York, New York.
0
 CEO
 WEBSITEcartesiangrowth.com/cgc2
 INDUSTRYShell Companies

Cartesian Growth Corporation II Frequently Asked Questions


What is the ticker symbol for Cartesian Growth Corporation II? What does RENE stand for in stocks?

RENE is the stock ticker symbol of Cartesian Growth Corporation II. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Cartesian Growth Corporation II (RENE)?

As of Fri Apr 26 2024, market cap of Cartesian Growth Corporation II is 63.77 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of RENE stock?

You can check RENE's fair value in chart for subscribers.

What is the fair value of RENE stock?

You can check RENE's fair value in chart for subscribers. The fair value of Cartesian Growth Corporation II is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Cartesian Growth Corporation II is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for RENE so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Cartesian Growth Corporation II a good stock to buy?

The fair value guage provides a quick view whether RENE is over valued or under valued. Whether Cartesian Growth Corporation II is cheap or expensive depends on the assumptions which impact Cartesian Growth Corporation II's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for RENE.